ADVFN US – Market Content Editor

  • Outlook Therapeutics Shares Plunge After FDA Rejects Wet AMD Therapy

    Outlook Therapeutics Shares Plunge After FDA Rejects Wet AMD Therapy

    Outlook Therapeutics (NASDAQ:OTLK) stock fell sharply, tumbling 70% in pre-market trading Thursday following the U.S. Food and Drug Administration’s (FDA) rejection of its ONS-5010/LYTENAVA (bevacizumab-vikg) application, intended as a treatment for wet age-related macular degeneration (wet AMD). The FDA issued a Complete Response Letter (CRL) for the company’s resubmitted Biologics License Application (BLA), citing a…

  • Genesco Shares Drop Over 8% Despite Sales Beat as Tariff Pressures Weigh on Profit

    Genesco Shares Drop Over 8% Despite Sales Beat as Tariff Pressures Weigh on Profit

    Genesco Inc. (NYSE:GCO) saw its shares fall 8.7% in pre-market trading Thursday after the footwear retailer reported second-quarter results that surpassed revenue expectations but were overshadowed by tariff-related profit pressures. The parent company of Journeys, Schuh, and Johnston & Murphy posted an adjusted loss of $1.14 per share for the quarter, better than the $1.25…

  • Dick’s Sporting Goods Boosts Full-Year Guidance After Strong Q2

    Dick’s Sporting Goods Boosts Full-Year Guidance After Strong Q2

    Dick’s Sporting Goods (NYSE:DKS) delivered better-than-expected results for its second quarter on Wednesday, posting record sales and raising its outlook for the full year as consumer demand remains robust. Following the announcement, the company’s shares climbed 1.9%. The retailer reported adjusted earnings per share of $4.38, surpassing analysts’ expectations of $4.30. Revenue for the quarter…

  • Dow Jones, S&P, Nasdaq, Futures, Wall Street Braces for Volatility Ahead of Inflation Data

    Dow Jones, S&P, Nasdaq, Futures, Wall Street Braces for Volatility Ahead of Inflation Data

    U.S. stock futures indicate a mostly flat open on Thursday, signaling a quiet start after the modest rally seen over the past two sessions. Investors are treading carefully as they weigh corporate earnings and upcoming economic indicators. Shares of Nvidia (NASDAQ:NVDA) fell 0.3% in pre-market trading. While the AI chipmaker exceeded second-quarter expectations overall, weaker-than-anticipated…

  • U.S. Economy Outperforms Expectations in Q2

    U.S. Economy Outperforms Expectations in Q2

    Revised figures released Thursday by the Commerce Department indicate that the U.S. economy expanded more than initially reported in the second quarter of 2025. Real gross domestic product (GDP) surged 3.3% in Q2, exceeding the prior estimate of a 3.0% increase and surpassing economists’ expectations for a 3.1% upward revision. The Commerce Department noted that…

  • Victoria’s Secret Stock Rises on Strong Q2 Results, Upgraded Outlook

    Victoria’s Secret Stock Rises on Strong Q2 Results, Upgraded Outlook

    Victoria’s Secret & Co. (NYSE:VSCO) saw its shares jump 7.5% on Thursday after the lingerie and beauty retailer delivered second-quarter earnings that surpassed Wall Street expectations and raised its full-year guidance, underscoring progress in its turnaround strategy. The company posted adjusted earnings per share of $0.33, well ahead of analyst projections of $0.13. Revenue reached…

  • Vanda Pharmaceuticals Jumps After FDA Grants Orphan Drug Status for PV Therapy

    Vanda Pharmaceuticals Jumps After FDA Grants Orphan Drug Status for PV Therapy

    Vanda Pharmaceuticals (NASDAQ:VNDA) shares climbed 6% after the company revealed that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to its investigational therapy VGT-1849B for the treatment of polycythemia vera (PV). VGT-1849B is a selective peptide nucleic acid-based JAK2 inhibitor aimed at treating PV, a chronic blood disorder that affects roughly…

  • Bath & Body Works Stock Slips After Weak Q3 Guidance

    Bath & Body Works Stock Slips After Weak Q3 Guidance

    Bath & Body Works, Inc. (NYSE:BBWI) reported second-quarter results on Thursday that met revenue expectations but missed slightly on earnings, sending its shares down 1.68% in premarket trading. The retailer, known for its home fragrance and personal care products, posted adjusted EPS of $0.37—just below analysts’ consensus of $0.38. Revenue came in at $1.55 billion,…

  • Dollar General Stock Jumps as Strong Q2 Results Prompt Higher Outlook

    Dollar General Stock Jumps as Strong Q2 Results Prompt Higher Outlook

    Dollar General (NYSE:DG) shares surged in premarket trading Thursday after the discount retailer reported second-quarter earnings that beat Wall Street estimates and raised its full-year guidance. The stock was up nearly 9% at 06:59 ET. For the quarter, the company posted earnings per share of $1.86, well ahead of the $1.57 consensus estimate. Revenue came…

  • Titan Machinery Beats Q2 Forecasts While Managing Weak Demand

    Titan Machinery Beats Q2 Forecasts While Managing Weak Demand

    Titan Machinery Inc. (NASDAQ:TITN) posted second-quarter results on Thursday that came in ahead of analyst expectations, as the farm and construction equipment dealer continued working through a difficult market while advancing its inventory reduction strategy. The company reported a net loss of $0.26 per share, narrower than the projected $0.48 per share loss. Revenue reached…